Understanding PSR and PCR Valuation Multiples

Go through these one at a time to build a fuller picture of how PSR and PCR work.

What is PSR (price-to-sales ratio)?

PSR stands for Price to Sales Ratio, calculated as market capitalization divided by revenue (or share price divided by revenue per share). Unlike PER, which depends on net income, PSR only needs revenue to calculate — which is why it's often used to compare relative valuation for companies that aren't yet profitable.

When PSR is especially useful

PSR is often used as a supplementary metric, in place of PER, when evaluating early-stage growth companies that are focused on revenue growth but not yet turning a profit, since PER can't be calculated when net income is negative. Paired with the revenue growth rate, it can help gauge how quickly the business is expanding.

PSR's limitation

Because PSR only looks at revenue, it says nothing about profitability, so comparing two companies with very different margins using PSR alone can be misleading — a much less profitable company can look artificially "cheap." PSR is most meaningful when comparing companies within the same industry and business model.

What is PCR (price-to-cash-flow ratio)?

PCR stands for Price to Cash Flow Ratio, calculated as market capitalization divided by operating cash flow (or share price divided by operating cash flow per share). Because it's less affected by non-cash accounting items like depreciation, it's often viewed as a more direct read on a company's actual cash-generating power than net income is.

PCR vs. PER

Net income can be shaped by accounting choices around depreciation, reserves, and similar items, while operating cash flow is comparatively harder to manipulate, so PCR is often used alongside PER as a check on earnings quality. If a company has a low PER but a comparatively high PCR, that can be a signal that its accounting profit isn't being backed up by matching cash generation.

Why look at several multiples together

PER, PBR, PSR, and PCR each look at company value from a different angle — earnings, net assets, revenue, and cash flow respectively — so relying on just one can distort the picture, while comparing several together helps reduce that risk. If PER looks distorted by a one-time gain, checking PCR or PSR alongside it can give a more balanced read on the underlying business.

Why comparing within the same industry matters

Neither PSR nor PCR has a universal "correct" benchmark, so both are most meaningful when compared against companies in the same industry and business model. Because typical margins and capital intensity vary so much by industry, comparing PSR or PCR across unrelated sectors can easily lead to the wrong conclusion.

How PSR and PCR complement PER and PBR

PER (price to earnings) and PBR (price to book) are the most familiar valuation ratios, but each has blind spots — PER breaks down when earnings are negative or distorted by one-off items, and PBR can miss the value of asset-light, intangible-heavy businesses. PSR fills the gap for unprofitable growth companies by using revenue instead of earnings, while PCR fills a different gap by checking whether reported profit is actually backed by real cash flow. Used together, the four ratios triangulate a company's valuation from several angles rather than relying on any single number.

Educational content, not investment advice

This page is general financial education about how valuation multiples work and isn't investment advice. It doesn't recommend any specific stock or product — before making any real investment decision, check current financial statements directly or consult a qualified professional.

Frequently Asked Questions

Is PSR alone enough to evaluate an unprofitable company?

PSR only reflects revenue, so it can't show differences in profitability on its own. Looking at revenue growth rate, margin trends, and cash flow (PCR) alongside it gives a more balanced picture.

Is PCR always more accurate than PER?

Not necessarily. PCR is less affected by accounting distortions, which is an advantage, but operating cash flow itself can swing significantly by industry capital intensity and investment cycle, so it isn't an absolute benchmark either.